Drug distributor’s profit climbs 32%
- Share via
McKesson Corp., the biggest U.S. drug distributor, said fiscal second-quarter profit increased 32% on higher sales of medicines and healthcare information systems.
Net income climbed to $327 million, or $1.17 a share, from $247 million, or 83 cents, a year earlier, San Francisco-based McKesson said. It attributed earnings of 27 cents a share to the release of a $76-million tax reserve. Earnings excluding special items missed analysts’ estimates.
Revenue for the three months ended Sept. 30 increased 8.7% to $26.6 billion.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
